Catalyst Wire Dossier Catalyst Wire Dossier

ABI-1968

Topical ABI-1968 · Antiva Biosciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABI-1968, covering 2019-02-07 to 2019-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection [Phase 1]

See pricing